GSE109619
Regulation of the positive transcriptional effect of PLZF through a non-canonical EZH2 activity
The transcription factor PLZF (promyelocytic leukemia zinc finger protein) acts as an epigenetic regulator balancing self-renewal and differentiation of hematopoietic cells through binding to various chromatin-modifying factors. First described as a transcriptional repressor, PLZF is also associated with active transcription, although the molecular bases underlying the differences are unknown. Here, we reveal that, in a hematopoietic cell line, PLZF is predominantly associated with transcribed genes. Additionally, we identify a new association between PLZF and the histone methyltransferase, EZH2 at the genomic level. We find that co-occupancy of PLZF and EZH2 on chromatin at PLZF target genes is not associated with SUZ12 or trimethylated lysine 27 of histone H3 (H3K27me3) but with the active histone mark H3K4me3 and active transcription. Removal of EZH2 leads to an increase of PLZF binding and increased in gene expression. Our results suggest a new role of EZH2 in restricting PLZF positive transcriptional activity independently of its canonical PRC2 activity. Overall design: PLZF, EZH2, SUZ12 and histone marks (H3K27me3, H3K4me3, H3K36me3) were analyzed using ChIPseq in human myeloblastic cell line (KG1) in wild-type (WT), shPLZF or shEZH2 conditions.  Each condition represents a merge of two biological replicates.